对于子宫内膜癌的内分泌疗法:传统的方法和新的目标
XiaoJing Guan1, RongRong Tang1, JianHua Yang1
1Department of Gynecology and Obstetrics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Frontiers in oncology
|May 20, 2025
概括
子宫内膜癌的治疗方法正在不断发展. 虽然传统的内分泌疗法面临局限性,但新型药物显示出改善子宫内膜癌患者生存结果的希望.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球子宫内膜癌的发病率正在上升.
- 内分泌疗法是子宫内膜癌的关键治疗方式,具有广泛的适用性和良好的耐受性.
- 传统的内分泌治疗方法,如孕激素,GnRH激动剂和芳酶抑制剂都有局限性,包括药物耐药性和复发.
研究的目的:
- 审查子宫内膜癌的传统和新型内分泌疗法的机制,方法和疗效.
- 突出新兴的内分泌制剂及其对生存结果的潜在影响.
主要方法:
- 临床前和临床研究的文献综述.
- 对各种内分泌制剂的作用机制的分析.
- 检查当前和新型治疗方法的疗效和局限性.
主要成果:
- 传统的内分泌疗法显示出有效性,但受阻力和复发性限制.
- 新型药物包括选择性雌激素受体调节剂 (SERM),选择性雌激素受体降解剂 (SERD),表观遗传疗法,mTOR抑制剂,CDK抑制剂和甲胺正在研究中.
- 初步数据表明,这些新药可能会改善子宫内膜癌患者的生存率.
结论:
- 内分泌治疗对于子宫内膜癌的管理至关重要.
- 新型内分泌药物代表了一个有前途的前沿,有可能克服当前治疗方法的局限性并改善患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319


